Skip to main content

Dr. Andrew B. Lassman, MD

Neurology (Neurology Physician)

  • Medicare participating

At a glance

Years since graduation
29
In the NPI registry since
2006
Medicare patients seen, 2024
17

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1997Medical school: Columbia University College of Physicians and Surgeons
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Neurology Physician primary
    NY license 210850

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Neurology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
17
Services billed
88
Patients’ average age
71
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes2212

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Payments from drug and device companies

In 2025, 3 companies reported 7 payments worth $5,314 in total to this clinician.

By company
Rigel Pharmaceuticals, Inc.$4,550
Deciphera Pharmaceuticals Inc.$675
Servier Pharmaceuticals LLC$88.92
By type
Consulting Fee$4,550
Compensation for services other than consulting (speaking, faculty)$675
Food and Beverage$88.92

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 24, 2025Rigel Pharmaceuticals, Inc.
Oct 24, 2025
Consulting Fee
TAVALISSE; Rezlidhia; Gavreto · Hematology
$1,625
Apr 25, 2025Rigel Pharmaceuticals, Inc.
Apr 25, 2025
Consulting Fee
TAVALISSE; Rezlidhia; Gavreto · Hematology
$1,625
Dec 2, 2025Deciphera Pharmaceuticals Inc.
Dec 2, 2025
Compensation for services other than consulting (speaking, faculty)$675
Jul 25, 2025Rigel Pharmaceuticals, Inc.
Jul 25, 2025
Consulting Fee
TAVALISSE; Rezlidhia; Gavreto · Hematology
$650
Sep 15, 2025Rigel Pharmaceuticals, Inc.
Sep 15, 2025
Consulting Fee
TAVALISSE; Rezlidhia; Gavreto · Hematology
$650

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in New York →

Industry-funded research

Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $27,233 in research payments for these studies, mostly to the institutions running them.

  • Study of vorasidenib, AG-881, in participants with residual or recurrent grade 2 glioma with an IDH1 or IDH2 mutation, indigo
    Servier Bioinnovation
  • A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Act…
    Incyte Corporation

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Neurology clinicians in New York

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 28, 2014), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1336110378. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.